Literature DB >> 29775238

Comparison of creatinine index and geriatric nutritional risk index for nutritional evaluation of patients with hemodialysis.

Wonsun Hwang1, Mi Sook Cho1, Ji Eun Oh2, Ji Hyun Lee3,4, Jong Cheol Jeong5, Gyu-Tae Shin5, Heungsoo Kim5, Inwhee Park5.   

Abstract

INTRODUCTION: Malnutrition is prevalent in hemodialysis (HD) patients, and the risk of mortality is strongly correlated with malnutrition. Current methods of nutritional evaluation are mostly subjective, time-consuming, and cumbersome. Creatinine index (CI) and geriatric nutritional risk index (GNRI) are very simple and objective methods to assess the nutritional status of HD patients. The present study compares the performance of CI and GNRI as nutritional risk assessment tools.
METHODS: Eighty-eight patients with end-stage renal disease on HD were recruited from a single tertiary center. A clinical dietitian carried out individual interviews of all patients and made nutritional diagnosis. Demographic and clinical data were also used to derive GNRI and CI over 4 months.
FINDINGS: Thirty-eight out of 88 patients (44%) were diagnosed with normal nutritional status. Twenty-two patients (25%) were diagnosed with severe malnutrition and 27 (31%) had moderate malnutrition. Compared with patients with severe malnutrition, the normal group and those with moderate malnutrition showed significantly higher levels of body mass index and GNRI. Even though GNRI was associated with CI, protein intake, uric acid, and normalized protein nitrogen were not significantly correlated with GNRI, whereas the markers were highly associated with CI (P = 0.000). GNRI enable the identification of the severe malnutrition group but not the normal and moderate-malnutrition groups. However, based on CI, the normal group was distinguished while those with severe and moderate malnutrition were not. DISCUSSION: Either CI or GNRI was a valid tool for longitudinal observation of nutritional status of patients on chronic HD and facilitated the screening of cases with malnutrition. Compared with GNRI, CI ranked higher in performance for the assessment and monitoring of nutritional status in HD patients.
© 2018 International Society for Hemodialysis.

Entities:  

Keywords:  Hemodialysis; creatinine index; geriatric nutritional risk index; nutritional status

Mesh:

Substances:

Year:  2018        PMID: 29775238     DOI: 10.1111/hdi.12674

Source DB:  PubMed          Journal:  Hemodial Int        ISSN: 1492-7535            Impact factor:   1.812


  4 in total

1.  Combined Evaluation of Geriatric Nutritional Risk Index and Modified Creatinine Index for Predicting Mortality in Patients on Hemodialysis.

Authors:  Takahiro Yajima; Kumiko Yajima; Maiko Arao
Journal:  Nutrients       Date:  2022-02-10       Impact factor: 5.717

2.  Safety and long-term improvement of mesenchymal stromal cell infusion in critically COVID-19 patients: a randomized clinical trial.

Authors:  Paulo Roberto Slud Brofman; Alejandro Correa; Carmen Lúcia Kuniyoshi Rebelatto; Alexandra Cristina Senegaglia; Claudio Luciano Franck; Debora Regina Daga; Patrícia Shigunov; Marco Augusto Stimamiglio; Daniela Boscaro Marsaro; Bruna Schaidt; Andressa Micosky; Ana Paula de Azambuja; Cleverson Alex Leitão; Ricardo Rasmussen Petterle; Valderez Ravaglio Jamur; Isadora May Vaz; Antônio Paulo Mallmann; Hipólito Carraro Junior; Eduardo Ditzel
Journal:  Stem Cell Res Ther       Date:  2022-03-21       Impact factor: 6.832

3.  Synergistic Effects of the Geriatric Nutritional Risk Index and the Modified Creatinine Index for Predicting Mortality in Patients on Hemodialysis.

Authors:  Takayuki Naito; Toshiki Doi; Kenichi Morii; Koji Usui; Michiko Arita; Kazuomi Yamashita; Kenichiro Shigemoto; Yoshiko Nishizawa; Sonoo Mizuiri; Kensuke Sasaki; Takao Masaki
Journal:  Nutrients       Date:  2022-06-09       Impact factor: 6.706

4.  Usefulness of computed tomography-measured psoas muscle thickness per height for predicting mortality in patients undergoing hemodialysis.

Authors:  Takahiro Yajima; Maiko Arao; Kumiko Yajima; Hiroshi Takahashi
Journal:  Sci Rep       Date:  2021-09-24       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.